Myelomeningocele (MMC) is a chronic disease that affects 0.3 to 0.72 per 1000 live-born
and stillborn babies in the United States. 1 MMC has a lifetime cost estimated at more than …

Fetal surgery began to show clinical potential in the 1980s, and since then has evolved into
a complex and diverse field. 1, 2 Over four decades of progress, the field has shown that the …

OBJECTIVE Neurosurgical management preferences related to myelomeningocele (MMC)
care demonstrate significant variability. The authors sought to evaluate variability in practice …

Objectives To report on the prenatal ultrasonographic diagnosis of spina bifida (SB) and its
natural history, treatment and long‐term outcome in a large tertiary referral center. Methods …

Objective Parents faced with the choice between postnatal management and prenatal
surgery for spina bifida need to have up‐to‐date information on the expected outcomes. The …

Objective Spina bifida disproportionally affects low-and-middle-income countries. We
describe myelomeningocele surgical outcomes in Zambia and predictors of postoperative …

Background There is a huge burden of neural tube defect (NTD) in Ethiopia, and surgical
management is not readily available. We aimed to assess the clinical profile and hospital …

Study design Retrospective cohort study. Objective To determine if topical vancomycin
irrigation reduces the incidence of post-operative surgical site infections following pediatric …

Objective Open spina bifida or myelomeningocele (MMC) is a congenital defect that results
from failure of caudal neurulation. We present a case series of patients who were treated …

BACKGROUND Appropriate timing for closure of myelomeningocele (MM) varies in the
literature. Older studies present 48 h as the timeframe after which infection complication …